11:15am ET
Health and Healthcare
Jefferies Identifies 5 Top Biotech Stocks for Huge Upside
Jefferies believes most of the significant biotech downside already occurred, though volatility could continue in the near term.
Companies
/Healthcare
Biomarin Pharmaceutical Inc
$63.94
▼ $1.14 (−1.75%) today
Markets closed · 3:05am ET
BMRN Coverage
Page 79:05am ET
Health and Healthcare
BioMarin Sinks Despite Meeting Primary Endpoint
BioMarin Pharmaceutical made waves early Monday following the release of late-stage results from its pegvaliase study.
Chris Lange 8:35am ET
Investing
4 Top Jefferies Growth Stocks to Buy With Big Upside Potential
A new research report from Jefferies focuses on a set of growth stocks for this week that have big upside. These four have some serious upside potential.
10:35am ET
Health and Healthcare
5 Key FDA Decisions Expected in March
24/7 Wall St. has collected three big FDA decisions coming up in March and added some color, along with the trading range and price target.
9:25am ET
Health and Healthcare
Top Biotech Stocks Dominate Jefferies Growth Stocks to Buy This Week
With biotechs still way out of favor, investors need to be cautious, as often these companies are dependent on binary data. These three could have positive upcoming data presented.
Lee Jackson 8:45am ET
Investing
Top Analyst Upgrades and Downgrades: Huntington Bancshares, Nucor, Orexigen, SanDisk, Square, VIVUS and Many More
The top analyst upgrades, downgrades and initiations seen on Monday, February 29, include Huntington Bancshares, Nucor, Orexigen Therapeutics, SanDisk, Square and VIVUS.
10:45am ET
Health and Healthcare
How Analysts Changed Views on BioMarin After Earnings
Investors really took to BioMarin Pharmaceuticals stock and there was a favorable jump after the fourth-quarter earnings report.
Chris Lange 11:45am ET
Health and Healthcare
Despite Market and Sector Risks, Why Credit Suisse Now Loves Top Biotechs
Credit Suisse sees solid fundamentals, despite a harsh market landscape, for large-cap biotech firms. It initiated several top biotech stocks with an Outperform rating.
8:55am ET
Investing
Top Analyst Upgrades and Downgrades: AMD, Amazon, Celgene, Comerica, Fortinet, Gilead, Lennar, Netflix, Voya, Wayfair and Many More
Wednesday's top analyst calls include AMD, Amazon.com, Celgene, Comerica, Fortinet, Gilead Sciences, Lennar, Netflix, Voya and Wayfair.
10:05am ET
Health and Healthcare
Why Sarepta Therapeutics Is Cratering
Sarepta Therapeutics plunged early on Friday as the result of a failed clinical trial by BioMarin Pharmaceutical.
10:15am ET
Health and Healthcare
4 Top FDA Decisions Expected in Q1
24/7 Wall St. has collected four companies big FDA decisions coming up in the first quarter of 2016 and added some color.
10:20am ET
Health and Healthcare
4 Top Jefferies Biotech and Specialty Pharma Growth Stocks to Buy Now
A new Jefferies research report focuses on some biotech and specialty pharmaceutical stocks that have had some headline and clinical issues muddy the waters.
8:40am ET
Investing
Top Analyst Upgrades and Downgrades: Apple, Bluebird, Exxon Mobil, Kinder Morgan, Kinross Gold, Lending Club, Perrigo and Many More
Wednesday's top analyst upgrades, downgrades and initiations include Apple, Bluebird, Exxon Mobil, Kinder Morgan, Kinross Gold, Lending Club and Perrigo.
8:40am ET
Investing
Hot Biotech Stocks Highlight Jefferies Top Growth Stocks to Buy This Week
This week the Jefferies analysts are positive on companies that took a shot price-wise last week and may be offering an even better entry point for investors.
9:41am ET
Investing
15 Fresh Analyst Stock Picks Called to Rise 50% to 100%
24/7 Wall St. tracked 15 fresh analyst calls in this past week alone in which analysts were calling for upside of almost 50% or more.